Myelodysplastic Syndrome (MDS)

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Fullerton, California
  • +219 more
Aug 24, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Birmingham, Alabama
  • +35 more
Aug 19, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor

Terminated
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Haplo-Cord Transplant
  • Matched Unrelated Donor Transplant
  • Chicago, Illinois
    University of Chicago Cancer Center
Feb 22, 2021

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

Completed
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +5 more
Mar 25, 2020

Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Completed
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
    • Stanford, California
    • +11 more
    Nov 12, 2019

    Acute Myelogenous Leukemia (AML), Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS) Trial in Chicago, Ann Arbor, Fairfax

    Unknown status
    • Acute Myelogenous Leukemia (AML)
    • +3 more
    • Chicago, Illinois
    • +2 more
    Apr 18, 2016